Aclarion (ACONW) Competitors $0.03 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, VSEE, and NTRAShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), and Natera (NTRA). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute VSee Health Natera American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, risk, profitability, valuation and earnings. Does the media prefer AONC or ACONW? In the previous week, American Oncology Network's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment American Oncology Network Neutral Aclarion Neutral Which has preferable valuation and earnings, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$54.60KN/AN/AN/AN/A Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A SummaryAmerican Oncology Network beats Aclarion on 1 of the 1 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$222.70M$5.49B$9.52BDividend YieldN/A5.90%4.73%4.09%P/E RatioN/A379.8128.7823.81Price / SalesN/A223.80372.2066.04Price / CashN/A47.1435.4557.96Price / BookN/A5.088.275.54Net IncomeN/A-$15.55M$3.25B$259.28M7 Day PerformanceN/A0.03%-3.70%-4.64%1 Month PerformanceN/A1.48%4.34%4.41%1 Year PerformanceN/A7.55%25.90%17.95% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.03flatN/A-29.0%$0.00$54.60K0.007AONCAmerican Oncology NetworkN/A$9.51-15.8%N/A+325.0%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.05-8.9%N/A-44.9%$0.00N/A0.00N/AGap DownFMSFresenius Medical Care AG & Co. KGaA3.5246 of 5 stars$27.20+1.5%$27.80+2.2%+33.8%$0.00$20.63B24.281,384LFMDPLifeMDN/A$23.95-1.0%N/A+9.6%$0.00$234.01M0.00230Upcoming EarningsHigh Trading VolumeOTRKPOntrakN/A$0.23-4.1%N/A-88.1%$0.00$10.84M0.00250Upcoming EarningsPIIIWP3 Health PartnersN/A$0.01-2.1%N/A-82.1%$0.00$1.49B0.00500Gap DownTALKWTalkspaceN/A$0.08+22.8%N/A-11.4%$0.00$194.36M0.00500TOIIWOncology InstituteN/A$0.12+3.5%N/A+352.0%$0.00$403.15M0.00660Gap UpVSEEVSee Health1.3512 of 5 stars$1.45+2.8%$5.00+244.8%-50.2%$0.00N/A0.00N/APositive NewsNTRANatera3.6987 of 5 stars$137.82-1.5%$184.63+34.0%+30.7%$19.11B$1.70B-93.754,434Trending NewsUpcoming EarningsInsider Trade Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives VSEE Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
